Zobrazeno 1 - 10
of 71
pro vyhledávání: '"R Sabarinathan, BE"'
Autor:
Manoj V Murhekar, MD, P Kamaraj, MPhil, Muthusamy Santhosh Kumar, MPH, Siraj Ahmed Khan, PhD, Ramesh Reddy Allam, MBBS, Pradip Barde, PhD, Bhagirathi Dwibedi, MD, Suman Kanungo, PhD, Uday Mohan, MD, Suman Sundar Mohanty, PhD, Subarna Roy, PhD, Vivek Sagar, PhD, Deepali Savargaonkar, MBBS, Babasaheb V Tandale, MD, Roshan Kamal Topno, MBBS, Gajanan Sapkal, PhD, C P Girish Kumar, PhD, R Sabarinathan, BE, Velusamy Saravana Kumar, PhD, Sailaja Bitragunta, MAE, Gagandeep Singh Grover, MD, P V M Lakshmi, MD, Chandra Mauli Mishra, MBBS, Provash Sadhukhan, PhD, Prakash Kumar Sahoo, PhD, S K Singh, MD, Chander Prakash Yadav, PhD, Asha Bhagat, MSc, Rashi Srivastava, MSc, E Ramya Dinesh, MSc, T Karunakaran, MSc, C Govindhasamy, MSc, T Daniel Rajasekar, MSc, A Jeyakumar, MPhil, A Suresh, MA, D Augustine, BA, P Ashok Kumar, BA, Rajesh Kumar, MD, Shanta Dutta, PhD, G S Toteja, PhD, Nivedita Gupta, PhD, Sanjay M Mehendale, MD
Publikováno v:
The Lancet Global Health, Vol 7, Iss 8, Pp e1065-e1073 (2019)
Summary: Background: The burden of dengue virus (DENV) infection across geographical regions of India is poorly quantified. We estimated the age-specific seroprevalence, force of infection, and number of infections in India. Methods: We did a communi
Externí odkaz:
https://doaj.org/article/8b0a72d513994c3f9938f87a5ef46f03
Autor:
Jeromie Wesley Vivian Thangaraj, Christine Prosperi, Muthusamy Santhosh Kumar, Alvira Z Hasan, V Saravana Kumar, Amy K Winter, Avi Kumar Bansal, Sanjay L Chauhan, Gagandeep Singh Grover, Arun Kumar Jain, Ragini N Kulkarni, Santanu Kumar Sharma, Biju Soman, Itta K Chaaithanya, Sanchit Kharwal, Sunil K Mishra, Neha R Salvi, Nilanju P Sarmah, Sandeep Sharma, Adarsh Varghese, R Sabarinathan, Augustine Duraiswamy, D Sudha Rani, K Kanagasabai, Abhishek Lachyan, Poonam Gawali, Mitali Kapoor, Saurabh Kumar Chonker, Lucky Sangal, Sanjay M Mehendale, Gajanan N Sapkal, Nivedita Gupta, Kyla Hayford, William J Moss, Manoj V Murherkar
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0297385 (2024)
BackgroundIn alignment with the Measles and Rubella (MR) Strategic Elimination plan, India conducted a mass measles and rubella vaccination campaign across the country between 2017 and 2020 to provide a dose of MR containing vaccine to all children a
Externí odkaz:
https://doaj.org/article/255664b88c654b8c96dd9d2602426f26
Autor:
Hemant Deepak Shewade, Asha Frederick, Madhanraj Kalyanasundaram, Joshua Chadwick, G. Kiruthika, T. Daniel Rajasekar, K. Gayathri, R. Vijayaprabha, R. Sabarinathan, Shri Vijay Bala Yogendra Shivakumar, Kathiresan Jeyashree, P. K. Bhavani, S. Aarthi, K. V. Suma, Delphina Peter Pathinathan, Raghavan Parthasarathy, M. Bhavani Nivetha, Jerome G. Thampi, Deiveegan Chidambaram, Tarun Bhatnagar, S. Lokesh, Shanmugasundaram Devika, Timothy S. Laux, Stalin Viswanathan, R. Sridhar, K. Krishnamoorthy, M. Sakthivel, S. Karunakaran, S. Rajkumar, M. Ramachandran, K. D. Kanagaraj, M. Kaleeswari, V. P. Durai, R. Saravanan, A. Sugantha, S. Zufire Hassan Mohamed Khan, P. Sangeetha, R. Vasudevan, R. Nedunchezhian, M. Sankari, N. Jeevanandam, S. Ganapathy, V. Rajasekaran, T. Mathavi, A. R. Rajaprakash, Lakshmi Murali, U. Pugal, K. Sundaralingam, S. Savithri, S. Vellasamy, D. Dheenadayal, P. Ashok, K. Jayasree, R. Sudhakar, K. P. Rajan, N. Tharageshwari, D. Chokkalingam, S. M. Anandrajkumar, T. S. Selvavinayagam, C. Padmapriyadarsini, Ranjani Ramachandran, Manoj V. Murhekar
Publikováno v:
Global Health Action, Vol 16, Iss 1 (2023)
Due to the workload and lack of a critical mass of trained operational researchers within their ranks, health systems and programmes may not be able to dedicate sufficient time to conducting operational research (OR). Hence, they may need the technic
Externí odkaz:
https://doaj.org/article/0c8d9c29b3f9428ba9604d15789727e3
Autor:
Tarun Bhatnagar, Sirshendu Chaudhuri, Manickam Ponnaiah, Pragya D Yadav, R Sabarinathan, Rima R Sahay, Faheem Ahmed, S Aswathy, Pankaj Bhardwaj, Anil Bilimale, M Santhosh Kumar, M. Logaraj, Uday Narlawar, C Palanivel, Prakash Patel, Sanjay K Rai, Vartika Saxena, Arvind Singh, Jeromie WV Thangaraj, Ashwini Agarwal, Yasir Alvi, Amoghashree, P Ashok, Dinesh Babu, Yogesh Bahurupi, Sangita Bhalavi, Priyamadhaba Behera, Priyanka Pandit Biswas, Jaykaran Charan, Nishant Kumar Chauhan, KB Chetak, Lalit Dar, Ayan Das, R Deepashree, Minakshi Dhar, Rahul Dhodapkar, TS Dipu, Mridu Dudeja, Manisha Dudhmal, Ravisekhar Gadepalli, Mahendra Kumar Garg, AV Gayathri, Akhil Dhanesh Goel, H Basavana Gowdappa, Randeep Guleria, Manoj Kumar Gupta, Farzana Islam, Mannu Jain, Vineet Jain, M Lanord Stanley Jawahar, Rajendra Joshi, Shashi Kant, Sitanshu Sekhar Kar, Deepjyoti Kalita, Meenakshi Khapre, Satyendra Khichar, Sarika Prabhakar Kombade, Sunil Kohli, Abhinendra Kumar, Anil Kumar, Deepak Kumar, Kiran G Kulirankal, KV Leela, Triparna Majumdar, Baijayantimala Mishra, Puneet Misra, Sanjeev Misra, Prasanta Raghab Mohapatra, M Narayana Murthy, Dimpal A Nyayanit, Manish Patel, Monika Pathania, Savita Patil, Binod Kumar Patro, Ramniwas Jalandra, Pragati Rathod, Naimesh Shah, Anita Shete, Deepak Shukla, M Shwethashree, Smita Sinha, MN Sumana, Ashish Surana, Anjan Trikha, A Tejashree, Mahalingam Venkateshan, G Vijaykrishnan, Sarita Wadhava, Naveet Wig, Nivedita Gupta, Priya Abraham, Manoj V Murhekar
Publikováno v:
International Journal of Infectious Diseases, Vol 122, Iss , Pp 693-702 (2022)
Objectives: India introduced BBV152/Covaxin and AZD1222/Covishield vaccines in January 2021. We estimated the effectiveness of these vaccines against severe COVID-19 among individuals aged ≥45 years. Methods: We did a multi-centric, hospital-based,
Externí odkaz:
https://doaj.org/article/ae9a4d01bbc948f5903a25216c64b295
Congenital rubella syndrome surveillance in India, 2016–21: Analysis of five years surveillance data
Autor:
Devika Shanmugasundaram, Sanjay Verma, Kuldeep Singh, Bhagirathi Dwibedi, Shally Awasthi, S. Mahantesh, Himabindu Singh, Sridhar Santhanam, Nivedita Mondal, Geetha S, Priya Sreenivasan, Shikha Malik, Manish Jain, Rajlakshmi Viswanathan, Shalini Tripathi, Bhupeshwari Patel, Gajanan Sapkal, R. Sabarinathan, Mini P. Singh, R.K. Ratho, Vijaylakshmi Nag, Ravishekhar Gadepalli, Tapas Kumar Som, Baijayantimala Mishra, Amita Jain, M. Ashok, Devara Sudha Madhuri, V Sudha Rani, Asha Mary Abraham, Deepa John, Rahul Dhodapkar, A. Syed Ali, Debasis Biswas, Deepashri Pratyeke, Ashish Bavdekar, Jayant Prakash, Varsha Singh, Nidhi Prasad, Jaydeb Ray, Agniva Majumdar, Shanta Dutta, Nivedita Gupta, Manoj Murhekar, Akhil Sharma, Aniruddha Ghosh, Arun Alexander, Arun Baranwal, Avinash Anantharaj, Adhisivam Bethou, Dolat S. Shekhawat, G. Kiruthika, Jagat Ram, Madhu Gupta, Mamatha Gowda, Manoj K Rohit, Nabaneeta Dash, Naveen Sankhyan, Nidhi Kaushal, Niranjan Hunasanahalli Shivanna, Nirupama Kasturi, P. Prem Kumar, Parul Chawla Gupta, Pradeep Kumar Gunasekaran, Pratibha Singh, Praveen Kumar, Sanjay Kumar Munjal, Siddharth Agarwal, Suhani Manasa, Suruchi Shukla, Urvashi Nehra, Valsan P Verghese, Varuna Vyas, Vikas Gupta
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15965- (2023)
Background: In India, facility-based surveillance for congenital rubella syndrome (CRS) was initiated in 2016 to estimate the burden and monitor the progress made in rubella control. We analyzed the surveillance data for 2016–2021 from 14 sentinel
Externí odkaz:
https://doaj.org/article/99b6729239fd42bfba7a7b945cee97be
Autor:
Manoj V. Murhekar, Muthusamy Santhosh Kumar, P. Kamaraj, Siraj Ahmed Khan, Ramesh Reddy Allam, Pradip Barde, Bhagirathi Dwibedi, Suman Kanungo, Uday Mohan, Suman Sundar Mohanty, Subarna Roy, Vivek Sagar, Deepali Savargaonkar, Babasaheb V. Tandale, Roshan Kamal Topno, C.P. Girish Kumar, R. Sabarinathan, Sailaja Bitragunta, Gagandeep Singh Grover, P.V.M. Lakshmi, Chandra Mauli Mishra, Provash Sadhukhan, Prakash Kumar Sahoo, S.K. Singh, Chander Prakash Yadav, Rajesh Kumar, Shanta Dutta, G.S. Toteja, Nivedita Gupta, Sanjay M. Mehendale, T. Karunakaran, Annamma Jose, D. Augustine, C. Govindhasamy, T. Daniel Rajasekar, A. Jeyakumar, A. Suresh, P. Ashok Kumar, R. Sivakumar, J.W. Banerjee John
Publikováno v:
International Journal of Infectious Diseases, Vol 100, Iss , Pp 455-460 (2020)
Introduction: India introduced a hepatitis-B (HB) vaccine in the Universal Immunization Program in 2002–2003 on a pilot basis, expanded to ten states in 2007–2008 (phase-1), and the entire country in 2011–2012 (phase-2). We tested sera from a n
Externí odkaz:
https://doaj.org/article/041600423739443aaf893abc72c9f644
Autor:
Sasikumar, Harishankar, Ganeshkumar, Parasuraman, R, Sabarinathan, Rubeshkumar, Polani, Venkatasamy, Vettrichelvan, Murhekar, Manoj
Publikováno v:
Transactions of the Royal Society of Tropical Medicine & Hygiene; May2024, Vol. 118 Issue 5, p336-338, 3p
Autor:
Manoj V Murhekar, Nivedita Gupta, Alvira Z Hasan, Muthusamy Santhosh Kumar, V Saravana Kumar, Christine Prosperi, Gajanan N Sapkal, Jeromie Wesley Vivian Thangaraj, Ojas Kaduskar, Vaishali Bhatt, Gururaj Rao Deshpande, Ullas Padinjaremattathil Thankappan, Avi Kumar Bansal, Sanjay L Chauhan, Gangandeep Singh Grover, Arun Kumar Jain, Ragini N Kulkarni, Santanu Kumar Sharma, Itta K Chaaithanya, Sanchit Kharwal, Sunil K Mishra, Neha R Salvi, Sandeep Sharma, Nilanju P Sarmah, R Sabarinathan, Augustine Duraiswamy, D Sudha Rani, K Kanagasabai, Abhishek Lachyan, Poonam Gawali, Mitali Kapoor, Arpit Kumar Shrivastava, Saurabh Kumar Chonker, Bipin Tilekar, Babasaheb V Tandale, Mohammad Ahmad, Lucky Sangal, Amy Winter, Sanjay M Mehendale, William J Moss, Kyla Hayford
Publikováno v:
The Lancet Global Health. 10:e1655-e1664
India did phased measles-rubella supplementary immunisation activities (MR-SIAs; ie, mass-immunisation campaigns) targeting children aged 9 months to less than 15 years. We estimated measles-rubella seroprevalence before and after the MR-SIAs to quan
Autor:
R. Sabarinathan, M Jagadeesan, Muthusamy Santhosh Kumar, D Sudha Rani, Cp Girish Kumar, Anita M. Shete, Abhinendra Kumar, Pragya D Yadav, Jeromie Wesley Vivian Thangaraj, Dimpal A Nyayanit, V Saravana Kumar, Manoj V Murhekar
Publikováno v:
Journal of Infection. 84:94-118
Autor:
Alvira Z. Hasan, Muthusamy Santhosh Kumar, Christine Prosperi, Jeromie Wesley Vivian Thangaraj, R. Sabarinathan, V. Saravanakumar, Augustine Duraiswamy, Ojas Kaduskar, Vaishali Bhatt, Gururaj Rao Deshpande, Padinjaremattathil Thankappan Ullas, Gajanan N. Sapkal, Lucky Sangal, Sanjay M. Mehendale, Nivedita Gupta, William J. Moss, Kyla Hayford, Manoj V. Murhekar
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
Serological surveillance for vaccine-preventable diseases, such as measles and rubella, can provide direct measures of population immunity across age groups, identify gaps in immunity, and document changes in immunity over time. Rigorously conducted,